AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast ...

Monday’s updated readout did not show new Grade 3 or higher cases of interstitial lung disease. Designed using Daiichi Sankyo ...

Clinical decision-making can be difficult for patients with SMA due to the lack of clinical trials comparing treatment ...

If rams are turned out in the next few weeks, we can expect lambs to begin showing up in early to mid-February. A successful ...

Imfinzi is a human monoclonal antibody that targets the PD-L1 protein, whereas Imjudo focuses on the CTLA-4 protein.